Determining meaningful thresholds for evaluating treatment efficacy in patients with alopecia areata
Ernest H. Law(Pfizer (United States)), Lauren Nelson(RTI Health Solutions), Randall H. Bender(RTI Health Solutions), Dane Korver(Triangle), Nicole J. Williams(Triangle), Debanjali Mitra(Pfizer (United States)), Gregor Schaefer(Humboldt-Universität zu Berlin)
Cited by 0
Related Papers
Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate‐to‐severe atopic dermatitis
|British Journal of Dermatology|2019|384
Assessing test–retest reliability of patient-reported outcome measures using intraclass correlation coefficients: recommendations for selecting and documenting the analytical formula
|Quality of Life Research|2018|247
Evaluating patient-perceived control of atopic dermatitis: design, validation, and scoring of the Atopic Dermatitis Control Tool (ADCT)
|Current Medical Research and Opinion|2019|138
Diffusion Tensor Measures of the Corpus Callosum in Adolescents With Adolescent Onset Alcohol Use Disorders
|Alcoholism Clinical and Experimental Research|2008|111
Preschool predictors of narrative writing skills in elementary school children.
|School Psychology Quarterly|2010|98